- Home
- BMY vs ASX Comparison
BMY vs ASX Comparison
Compare BMY & ASX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMY | ASX |
|---|---|---|
| Founded | 1887 | 1984 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.5B | 81.0B |
| IPO Year | 2006 | 2000 |
Fundamental Metrics
Financial Performance| Metric | BMY | ASX |
|---|---|---|
| Price | $67.28 | $36.24 |
| Analyst Decision | Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $61.73 | N/A |
| AVG Volume (30 Days) | ★ 11.9M | 8.1M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | ★ 4.38% | 0.85% |
| EPS Growth | ★ 178.46 | N/A |
| EPS | ★ 2.93 | N/A |
| Revenue | ★ $48,194,000,000.00 | N/A |
| Revenue This Year | N/A | $19.16 |
| Revenue Next Year | N/A | $16.13 |
| P/E Ratio | ★ $22.87 | $38.05 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $42.52 | $9.86 |
| 52 Week High | $68.64 | $45.52 |
Technical Indicators
Market Signals| Indicator | BMY | ASX |
|---|---|---|
| Relative Strength Index (RSI) | 63.48 | 45.32 |
| Support Level | $56.46 | $30.50 |
| Resistance Level | $68.10 | $40.70 |
| Average True Range (ATR) | 1.51 | 1.43 |
| MACD | 0.04 | -0.13 |
| Stochastic Oscillator | 72.52 | 18.42 |
Price Performance
Historical ComparisonAbout BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About ASX ASE Technology Holding Co. Ltd. (each representing Two)
ASE Technology Holding Co Ltd is a semiconductor assembly and testing firm. The company operates in segments: Packaging, Testing, Electronic Manufacturing Services and others. Of these, Packaging segment contribute the maximum revenue. The packaging segment involves packaging bare semiconductors into completed semiconductors with improved electrical and thermal characteristics. The Testing Segment includes front-end engineering testing, wafer probing, and final testing services. In the EMS segment, the company designs manufactures, and sells electronic components and telecommunication equipment motherboards. The company is based in Taiwan but generates over half its sales from firms in the United States.